Atypical background somatic mutant frequencies at the HPRT locus in children and adults with down syndrome

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 403, Issue 1-2, 1998, Pages 35-43

  Finette, B A ^a,b,d   Rood, B ^a   Poseno, T ^b   Vacek, P ^b   Pueschel, S ^c   Homans, A C ^a,b  

^a UNIVERSITY OF VERMONT   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^c RHODE ISLAND HOSPITAL   (United States)

^d NONE   (United States)

Author keywords

Down syndrome; Hypoxanthine guanine phosphoribosyl transferase (HPRT); Mutant frequency

Indexed keywords

HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE;

ADOLESCENT; ADULT; ARTICLE; CANCER RISK; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; GENDER; GENE LOCUS; HUMAN; HUMAN CELL; INFANT; LEUKEMIA; LEUKEMOGENESIS; MALE; MUTATION RATE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; T LYMPHOCYTE;

ADOLESCENT; ADULT; AGE FACTORS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DNA DAMAGE; DNA REPAIR; DOWN SYNDROME; FEMALE; GENES, REPORTER; HUMANS; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; INFANT; LEUKEMIA; MALE; MIDDLE AGED; MUTATION; T-LYMPHOCYTES;

EID: 0032540912     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(98)00024-4     Document Type: Article

References (38)

1. [1] L.A. Loeb, Microsatellite instability: marker of a mutator phenotype in cancer, Cancer Res. 54 (1994) 5059-5063.
2. [2] B. Vogelstein, K.W. Kinzler, The multistep nature of cancer, Trends Genet. 9 (4) (1993) 138-141.
3. [3] L.L. Robison, M.J. Nesbit, H.N. Sather, C. Level, N. Shahidi, A. Kennedy, D. Hammond, Down syndrome and acute leukemia in children: a 10-year retrospective survey from children's cancer study group, J. Pediatr. 105 (2) (1984) 235-242.
4. [4] M. Watson, A. Carroll, J. Shuster, R.C. Steube, F. Borowitz, F. Behm, D. Pullen, V. Land, Trisomy 21 in childhood acute lymphoblastic leukemia: a pediatric oncology group study (8602), Blood 82 (1993) 3098-3102.
5. [5] J. Pincheira, M. Rodriguez, M. Bravo, M.H. Navarette, J.F. Lopez-Saez, Defective G2 repair in Down syndrome: effect of caffeine, adenosine and niacinamide in control and X-ray irradiated lymphocytes, Clin. Genet. 45 (1994) 25-31.
6. [6] R.J. Albertini, K.L. Castle, W.R. Borcherding, T-cell cloning to detect the mutant 6-thioguanine-resistant lymphocytes present in human peripheral blood, Proc. Natl. Acad. Sci. U.S.A. 79 (1982) 6617-6621.
7. [7] R.J. Albertini, J.A. Nicklas, J.P. O'Neill, S.H. Robbins, In vivo somatic mutations in humans: Measurement and analysis, Annu. Rev. Genet. 24 (1990) 305-326.
8. [8] R.J. Albertini, J.P. O'Neill, J.A. Nicklas, L. Recio, T.R. Skopek (Eds.), HPRT mutations in vivo in human T-lymphocytes: frequencies, spectra and clonality, in: M.L. Mendelsohn, R.J. Albertini (Eds.), Mutation and the Environment: Somatic and Heritable Mutation, Adduction and Epidemiology: Progress in Clinical and Biological Research, Part C, Whiley-Liss, New York, 1990, pp. 15-24.
9. [9] N.F. Cariello, T.R. Skopek, Analysis of mutations occurring at the human HPRT locus, J. Mol. Biol. 231 (1993) 41-57.
10. [10] N.F. Cariello, T.R. Skopek, In vivo mutation at the human HPRT locus, Trends Genet. 9 (9) (1993) 322-326.
11. [11] D. Robinson, K. Goodall, R.J. Albertini, J.P. O'Neill, B.A. Finette, M. Sala-Trepat, A.D. Tates, D. Beare, M.H.L. Green, J. Cole, An analysis of in vivo HPRT mutant frequency in circulating T-lymphocytes in the normal human population: a comparison of four databases, Mutat. Res. 313 (1994) 227-247.
12. [12] A.D. Tates, F.J. van Dam, H. van Mossel, H. Schoemaker, J.C.P. Thijssen, V.M. Woldring, A.M. Zwinderman, A.T. Natarajan, Use of the clonal assay for the measurement of frequencies of HPRT mutants in T-lymphocytes from five control populations, Mutat. Res. 253 (1991) 199-213.
13. [13] B.A. Finette, T. Poseno, P.M. Vacek, R.J. Albertini, The effects of maternal cigarette smoke exposure on somatic mutant frequencies at the HPRT locus in healthy newborns, Mutat. Res. 377 (1997) 115-123.
14. [14] M.J. McGinniss, M.T. Falta, L.S. Sullivan, R.J. Albertini, In vivo HPRT mutant frequencies in T-cells of normal human newborns, Mutat. Res. 240 (1990) 117-126.
15. [15] B.A. Finette, L.M. Sullivan, J.P. O'Neil, J.A. Nicklas, P.M. Vacek, R.J. Albertini, Determination of HPRT mutant frequencies in T-lymphocytes from a healthy pediatric population: statistical comparison between newborn, children and adult mutant frequencies, cloning efficiency and age, Mutat. Res. 308 (1994) 223-231.
16. [16] R.F. Branda, L.M. Sullivan, J.P. O'Neil, M.T. Falta, J.A. Nicklas, B. Hirsch, P.M. Vacek, R.J. Albertini, Measurement of HPRT mutant frequencies in T-Lymphocytes from healthy human populations, Mutat. Res. 285 (1993) 267-279.
17. [17] J.P. O'Neill, M.J. McGinniss, J.K. Berman, L.M. Sullivan, J.A. Nicklas, R.J. Albertini, Refinement of a T-lymphocyte cloning assay to quantify the in vivo thioguanine-resistant mutant frequency in humans, Mutagenesis, 1987, pp. 87-92.
18. [18] L. Henderson, J. Cole, H. Cole, S.E. James, M. Green, Detection of somatic mutations in man: evaluation of the microtiter cloning assay for T-lymphocytes, Mutagenesis 1 (1986) 195-200.
19. [19] M.M. Ammenheuser, A.B. Berenson, N.J. Stiglich, E.B. Whorton, J.B. Ward, Elevated frequencies of HPRT mutant lymphocytes in cigarette-smoking mothers and their newborns, Mutat. Res. 304 (1994) 285-294.
20. [20] A.C. Homans, J.L. Cohen, E.M. Mazur, Defective in vitro hematopoiesis in patients with Down Syndrome, Pediatr. Res. 25 (125A) (1989) Abstract.
21. [21] P. Ramila, A.C. Berger, N.H. McManus, N.H. Warner, M.A. Peacock, L.B. Epstein, Abnormalities of the in vitro cellular and humoral responses to tetanus and influenza antigens with concomitant numerical alterations in lymphocyte subsets in Down syndrome (trisomy 21), J. Immunol. 136 (5) (1986) 1661-1667.
22. [22] L.B. Epstein, C.J. Epstein, T-lymphocyte function and sensitivity to interferon in trisomy 21, Cell. Immunol. 51 (1980) 303.
23. [23] G.R. Burgio, A.G. Ugazio, L. Nespoli, A.F. Marcioni, A.M. Bottelli, F. Pasquali, Derangements of immunoglobulin levels, phytohemagglutinin responsiveness and T and B cell markers in Down's syndrome at different ages, Eur. J. Immunol. 5 (1975) 600-603.
24. [24] S. Levin, M. Schlesinger, Z. Handzel, T. Hahn, Y. Altman, B. Czernobilsky, J. Boss, Thymic deficiency in Down's syndrome, Pediatrics 63 (1) (1979) 80-87.
25. [25] C.A. Spina, D. Smith, E. Korn, J.L. Fahey, H.J. Grossman, Altered cellular immune functions in patients with Down's syndrome, Am. J. Dis. Children 135 (1981) 251-255.
26. 1, Clin. Immunol. Immunopathol. 62 (2) (1992) 245-251.
27. [27] M. Peled-Kamar, J. Lotem, E. Okon, L. Sachs, Y. Groner, Thymic abnormalities and enhanced apoptosis of thymocytes and bone marrow cells in transgenic mice overexpressing Cu/Zn-superoxide dismutase: implications for Down syndrome, EMBO J. 14 (20) (1995) 4985-4993.
28. [28] J. Busciglio, B.A. Yankner, Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro, Nature 378 (1995) 776-779.
29. [29] H. Vaziri, F. Schacter, I. Uchida, L. Wei, X. Zhu, R. Effros, D. Cohen, C.B. Harley, Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes, Am. J. Hum. Genet. 52 (1993) 661-667.
30. [30] Vijayalaxmi, H.J. Evans, Bleomycin-induced chromosomal aberrations in Down's syndrome lymphocytes, Mutat. Res. 105 (1982) 107-113.
31. [31] M.S. Sasaki, A. Tonomura, S. Matsubara, Chromosome constitution and its bearing on the chromosomal radiosensitivity in man, Mutat. Res. 10 (1970) 617-633.
32. [32] T. Takeshita, C. Ariizumi-Shibusawa, H.H.K. Shimizu, S.I.Z. Yamagata, A. Asaka, M. Higurashi, The effect of aging on cell-cycle kinetics and X-ray induced chromosome aberrations in cultured lymphocytes from patients with Down syndrome, Mutat. Res. 275 (1992) 21-29.
33. [33] P. Gadhia, M. Gadhia, H. Zankl, Effects of bleomycin on Down's syndrome lymphocytes in culture, Mutat. Res. 207 (1988) 153-158.
34. [34] K. Iilima, K. Morimoto, A. Koizumi, M. Higurashi, M. Hirayama, Bleomycin-induced chromosomal aberrations and sister chromatid exchanges in Down lymphocyte cultures, Hum. Genet. 66 (1984) 57-61.
35. [35] H.M. Shafik, W.W. Au, M.S. Legator, Chromosomal radiosensitivity of Down syndrome lymphocytes at different stages of the cell cycle, Hum. Genet. 78 (1988) 71-75.
36. [36] T.C. Reeja, N. Chandra, K.M. Marimuthu, Chromosomal breakpoints in irradiated and ethyl methane sulphonate-treated leukocytes of patients with Down syndrome, Indian J. Exp. Biol. 31 (1993) 201-205.
37. [37] I. Kalina, H. Knonecna, G. Nemethova, N. Racekova, Adaptive response to ionizing radiation in norma and aneuploid human lymphocytes, Folia Biol. 40 (3) (1994) 119-123.
38. [38] B.A. Finette, T. Poseno, R.J. Albertini, V(D)J recombinase-mediated HPRT mutations in peripheral blood lymphocytes of normal children, Cancer Res. 56 (1996) 1405-1412.